|
H6: code c19 - a review of the manufacturing records indicated the lot met all pre-release specifications.H6: code b20 -the device remains implanted and was therefore not available for engineering evaluation by gore.According to the gore® excluder® conformable aaa endoprosthesis instructions for use (ifu), potential adverse events that may occur and/or require intervention include, but are not limited to bleeding and death.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
The following was reported to gore: on (b)(6) 2023, the patient underwent an endovascular procedure in the ascending aorta to treat a pseudoaneurysm utilizing a gore® excluder® conformable aaa endoprosthesis (aortic extender).Reportedly, the ascending aorta was curved and the device did not take the curve (proximal) and had not apposed the wall on the inner curve which led to a slight bird beak.Physician believed the device covered the defect (pseudoaneurysm) and it was a difficult application/angle to treat.The slight bird beak did not seem to affect the outcome of the procedure and patient is doing well after 2 days of post op.Additional information received from fsa on 09/28/2023: last night ((b)(6) 2023).Fsa was informed by a dr.(b)(6) (who was apparently also at the initial procedure) that the patient passed away on an unknown date after the procedure.The cause of death was persistent bleeding.No further information or details are available as to what led to the persistent bleeding.It was also reported that the aortic extender conformable was initially placed through the patient's neck and into the aortic arch near the heart.The patient also had a previous heart transplant.
|